. Author manuscript; available in PMC: 2020 Nov 8.

Published in final edited form as: Echocardiography. 2019 Nov 8;36(11):2033–2040. doi: 10.1111/echo.14518

Table 3.

Strain Values by Treatment Group

2D-STE Values	Treatment Group	Pre-Treatment (± SD)	Post-Treatment (± SD)	P-value
Average Global Longitudinal Strain (%)	Clofarabine	17.9 ± 3.3	−18.2 ± 2.7	0.68
Average Global Longitudinal Strain (%)	7+3	−19.1 ± 2.8	−17.2 ± 3.0	0.01
Two-chamber Longitudinal Strain (%)	Clofarabine	−18.3 ± 3.3	−17.6 ± 1.7	0.34
Two-chamber Longitudinal Strain (%)	7+3	−19.6 ± 2.7	−17.5 ± 2.7	0.015
Three-chamber Longitudinal Strain (%)	Clofarabine	−16.8 ± 5.5	−17.7 ± 4.2	0.60
Three-chamber Longitudinal Strain (%)	7+3	−19.5 ± 4.4	−16.1 ± 2.9	0.011
Four-chamber Longitudinal Strain (%)	Clofarabine	−18.0 ± 3.2	−19.3 ± 4.2	0.31
Four-chamber Longitudinal Strain (%)	7+3	−18.5 ± 3.6	−16.6 ± 3.5	0.08
Circumferential Strain (%)	Clofarabine	−26.1 ± 8.5	−26.6 ± 7.6	0.82
Circumferential Strain (%)	7+3	−29.4 ± 6.3	−23.9 ± 4.3	0.011